Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 24, Issue 7, 2012, Pages 820-827

  Tsui, Judith I ^a   Cheng, Debbie M ^a,b   Libman, Howard ^c   Bridden, Carly ^a   Samet, Jeffrey ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cytokines; hepatitis C; pain; peripheral neuropathy; symptoms

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; ALCOHOLISM; ARTHRALGIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ABUSE; EXPLORATORY RESEARCH; FEMALE; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIXED INFECTION; MYALGIA; PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SMOKING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACTIVITIES OF DAILY LIVING; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALCOHOLISM; ARTHRALGIA; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HEPATITIS C; HUMANS; INFLAMMATION; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84863671031     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2011.642989     Document Type: Article

References (52)

1. Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., & Alter, M.J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705-714.
2. Bair, M.J., Robinson, R.L., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine, 163(20), 2433-2445.
3. Barkhuizen, A., Rosen, H.R., Wolf, S., Flora, K., Benner, K., & Bennett, R.M. (1999). Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. American Journal of Gastroenterology, 94(5), 1355-1360.
4. Baron, R.M., & Kenny, D.A. (1986). The moderatormediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
5. Breitbart, W., Passik, S., McDonald, M.V., Rosenfeld, B., Smith, M., Kaim, M., & Funesti-Esch, J. (1998). Patient-related barriers to pain management in ambulatory AIDSpatients. Pain, 76(1-2), 9-16.
6. Breitbart, W., Rosenfeld, B., Passik, S., Kaim, M., Funesti- Esch, J., & Stein, K. (1997). A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDSpatients with and without a history of substance abuse. Pain, 72(1-2), 235-243.
7. Brennan, P.L., Schutte, K.K., & Moos, R.H. (2005). Pain and use of alcohol to manage pain: Prevalence and 3-year outcomes among older problem and nonproblem drinkers. Addiction, 100(6), 777-786.
8. Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., Piette, J.C. (2000). Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore), 79(1), 47-56.
9. Caldeiro, R.M., Malte, C.A., Calsyn, D.A., Baer, J.S., Nichol, P., Kivlahan, D.R., & Saxon, A.J. (2008). The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction, 103(12), 1996-2005.
10. Carrat, F., Bani-Sadr, F., Pol, S., Rosenthal, E., Lunel- Fabiani, F., Benzekri, A., ANRSHCO2 RIBAVIC Study Team. (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. Journal of the American Medical Association, 292(23), 2839-2848.
11. Compton, P., Charuvastra, V.C., Kintaudi, K., & Ling, W. (2000). Pain responses in methadone-maintained opioid abusers. Journal of Pain and Symptom Management, 20(4), 237-245.
12. Compton, P., Charuvastra, V.C., & Ling, W. (2001). Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug and Alcohol Dependence, 63(2), 139-146.
13. Del Borgo, C., Izzi, I., Chiarotti, F., Del Forno, A., Moscati, A.M., Cornacchione, E., & Fantoni, M. (2001). Multidimensional aspects of pain in HIVinfected individuals. AIDS Patient Care STDS, 15(2), 95-102.
14. Dobalian, A., Tsao, J.C., & Duncan, R.P. (2004). Pain and the use of outpatient services among persons with HIV: Results from a nationally representative survey. Medical Care, 42(2), 129-138.
15. Doverty, M., White, J.M., Somogyi, A.A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90(1-2), 91-96.
16. Dwight, M.M., Kowdley, K.V., Russo, J.E., Ciechanowski, P.S., Larson, A.M., & Katon, W.J. (2000). Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research, 49(5), 311-317.
17. el-Serag, H.B., Kunik, M., Richardson, P., & Rabeneck, L. (2002). Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology, 123(2), 476-482.
18. Fontana, R.J., Hussain, K.B., Schwartz, S.M., Moyer, C.A., Su, G.L., & Lok, A.S. (2002). Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology, 36(3), 401-407.
19. Garfein, R.S., Vlahov, D., Galai, N., Doherty, M.C., & Nelson, K.E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5), 655-661.
20. Golden, J., O'Dwyer, A.M., & Conroy, R.M. (2005). Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. General Hospital Psychiatry, 27(6), 431-438.
21. Golub, E.T., Latka, M., Hagan, H., Havens, J.R., Hudson, S.M., Kapadia, F., Strathdee, S.A. (2004). Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory. Journal of Urban Health, 81(2), 278-290.
22. Hewitt, D.J., McDonald, M., Portenoy, R.K., Rosenfeld, B., Passik, S., & Breitbart, W. (1997). Pain syndromes and etiologies in ambulatory AIDSpatients. Pain, 70(2-3), 117-123.
23. Holahan, C.J., Moos, R.H., Holahan, C.K., Cronkite, R.C., & Randall, P.K. (2001). Drinking to cope, emotional distress and alcohol use and abuse: A ten-year model. Journal of Studies on Alcohol, 62(2), 190-198.
24. Jacobson Brown, P.M., & Neuman, M.G. (2001). Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. Clinical Biochemistry, 34(3), 167-171.
25. Justice, A.C., Holmes, W., Gifford, A.L., Rabeneck, L., Zackin, R., Sinclair, G., Adult AIDSClinical Trials Unit Outcomes Committee. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54(Suppl. 1), S77-S90.
26. Laskus, T., Radkowski, M., Adair, D.M., Wilkinson, J., Scheck, A.C., & Rakela, J. (2005). Emerging evidence of hepatitis C virus neuroinvasion. AIDS, 19(Suppl. 3), S140-S144.
27. Lee, D.H., Jamal, H., Regenstein, F.G., & Perrillo, R.P. (1997). Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Digestive Diseases and Sciences, 42(1), 186-191.
28. Libman, H., Saitz, R., Nunes, D., Cheng, D.M., Richardson, J.M., Vidaver, J., & Samet, J.H. (2006). Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems. American Journal of Gastroenterology, 101(8), 1804-1810.
29. Loftis, J.M., Huckans, M., & Morasco, B.J. (2010). Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiology of Disease, 37(3), 519-533.
30. Loftis, J.M., Huckans, M., Ruimy, S., Hinrichs, D.J., & Hauser, P. (2008). Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neuroscience Letters, 430(3), 264-268.
31. Lorvick, J., Kral, A.H., Seal, K., Gee, L., & Edlin, B.R. (2001). Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. American Journal of Public Health, 91(1), 46-47.
32. Martin, C., Pehrsson, P., Osterberg, A., Sonnerborg, A., & Hansson, P. (1999). Pain in ambulatory HIV-infected patients with and without intravenous drug use. European Journal of Pain, 3(2), 157-164.
33. Murrill, C.S., Weeks, H., Castrucci, B.C., Weinstock, H.S., Bell, B.P., Spruill, C., & Gwinn, M. (2002). Agespecific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 UScities. American Journal of Public Health, 92(3), 385-387.
34. Perry, W., Hilsabeck, R.C., & Hassanein, T.I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53(2), 307-321.
35. Richardson, J.L., Heikes, B., Karim, R., Weber, K., Anastos, K., & Young, M. (2009). Experience of pain among women with advanced HIV disease. AIDS Patient Care STDS, 23(7), 503-511.
36. Riley, E.D., Wu, A.W., Perry, S., Clark, R.A., Moss, A.R., Crane, J., & Bangsberg, D.R. (2003). Depression and drug use impact health status among marginally housed HIV-infected individuals. AIDS Patient Care STDS, 17(8), 401-406.
37. Saitz, R. (2005). Clinical practice. Unhealthy alcohol use. New England Journal of Medicine, 352(6), 596-607.
38. Samet, J.H., Phillips, S.J., Horton, N.J., Traphagen, E.T., & Freedberg, K.A. (2004). Detecting alcohol problems in HIV-infected patients: Use of the CAGE questionnaire. AIDS Research and Human Retroviruses, 20(2), 151-155.
39. Silberbogen, A.K., Janke, E.A., & Hebenstreit, C. (2007). A closer look at pain and hepatitis C: Preliminary data from a veteran population. Journal of Rehabilitation Research and Development, 44(2), 231-244.
40. Spiegel, B.M., Younossi, Z.M., Hays, R.D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology, 41(4), 790-800.
41. Sulkowski, M.S., & Thomas, D.L. (2003). Hepatitis C in the HIV-infected person. Annals of Internal Medicine, 138(3), 197-207.
42. Thomas, D.L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K.E. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore), 74(4), 212-220.
43. Thompson, M.E., & Barkhuizen, A. (2003). Fibromyalgia, hepatitis C infection, and the cytokine connection. Current Pain and Headache Reports, 7(5), 342-347.
44. Torriani, F.J., Rodriguez-Torres, M., Rockstroh, J.K., Lissen, E., Gonzalez-Garcia, J., Lazzarin, A., APRICOT Study Group. (2004). Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine, 351(5), 438-450.
45. Tsao, J.C., Dobalian, A., & Naliboff, B.D. (2004). Panic disorder and pain in a national sample of persons living with HIV. Pain, 109(1-2), 172-180.
46. Tsao, J.C., Dobalian, A., & Stein, J.A. (2005). Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. Pain, 119 (1-3), 124-132.
47. Uceyler, N., & Sommer, C. (2008). Cytokine regulation in animal models of neuropathic pain and in human diseases. Neuroscience Letters, 437(3), 194-198.
48. Verri, W.A., Jr., Cunha, T.M., Parada, C.A., Poole, S., Cunha, F.Q., & Ferreira, S.H. (2006). Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development? Pharmacology & Therapeutics, 112(1), 116-138.
49. Vogl, D., Rosenfeld, B., Breitbart, W., Thaler, H., Passik, S., McDonald, M., & Portenoy, R.K. (1999). Symptom prevalence, characteristics, and distress in AIDSoutpatients. Journal of Pain and Symptom Management, 18(4), 253-262.
50. Ware, J.E., Kosinski, M., & Keller, S.D. (1996). A 12-item short form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(4), 220-233.
51. Watkins, L.R., Hutchinson, M.R., Milligan, E.D., & Maier, S.F. (2007). "Listening" and "talking" to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids. Brain Research Reviews, 56(1), 148-169.
52. Whitehead, A.J., Dobscha, S.K., Morasco, B.J., Ruimy, S., Bussell, C., & Hauser, P. (2008). Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of Pain and Symptom Management, 36(1), 39-45.